#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4418132	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated anion exchange at 25 uM incubated for 10 mins by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	22		cell-based format	Patent Bioactivity Data
2.	ALA4418133	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17SCN(-) exchange incubated for 10 mins by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
3.	ALA4418134	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17F exchange incubated for 10 mins by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
4.	ALA4418135	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated Cl(-)/r exchange incubated for 10 mins by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
5.	ALA4418136	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17NO3(-) exchange incubated for 10 mins by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
6.	ALA4418137	B	Reversible inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17SCN(-) exchange incubated for 10 mins measured after wash out by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
7.	ALA4418138	B	Time dependent inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17SCN(-) exchange by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
8.	ALA4418139	B	Inhibition of human pendrin expressed in FRT cells co-expressing EYFP-HIF assessed as reduction in pendrin-mediated C17HCO3(-) exchange by measuring reduction in cytoplasmic alkalinization exchange at 25 uM by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
9.	ALA4418158	B	Inhibition of mouse pendrin expressed in FRT cells co-expressing YFP-HIF assessed as reduction in pendrin-mediated exchange of Cl(-) with SCN(-) by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Mus musculus	1		cell-based format	Patent Bioactivity Data
10.	ALA4418159	B	Inhibition of mouse pendrin expressed in FRT cells co-expressing YFP-HIF assessed as reduction in pendrin-mediated exchange of Cl(-) with I(-) by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Mus musculus	1		cell-based format	Patent Bioactivity Data
11.	ALA4418160	B	Inhibition of mouse pendrin expressed in FRT cells co-expressing YFP-HIF assessed as reduction in pendrin-mediated exchange of Cl(-) with NO3(-) by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Mus musculus	1		cell-based format	Patent Bioactivity Data
12.	ALA4418161	B	Inhibition of mouse pendrin expressed in FRT cells co-expressing YFP-HIF assessed as reduction in pendrin-mediated kinetics of CI7HCO3(-) exchange by pH-sensitive fluorescent probe BCECF-AM based fluorescence assay relative to control	Mus musculus	1		cell-based format	Patent Bioactivity Data
13.	ALA4418162	B	Inhibition of mouse Slc4a1 expressed in COS7 co-expressing EYFP-HIF assessed as effect on SCN(-) gradient at 25 uM by YFP-based fluorescence quenching assay	Mus musculus	1		assay format	Patent Bioactivity Data
14.	ALA4418163	B	Inhibition of myc-tagged mouse Slc26a3 expressed in COS7 co-expressing EYFP-HIF assessed as effect on SCN(-) gradient at 25 uM by YFP-based fluorescence quenching assay	Mus musculus	1		assay format	Patent Bioactivity Data
15.	ALA4418164	B	Inhibition of human NKCC1 expressed in COS7 co-expressing EYFP-HIF assessed as effect on I(-) gradient at 25 uM by YFP-based fluorescence quenching assay	Homo sapiens	1		assay format	Patent Bioactivity Data
16.	ALA4418165	A	Effect on renal function in CD1 mouse assessed as effect on urine pH at 50 mg/kg, ip	Mus musculus	2		organism-based format	Patent Bioactivity Data
17.	ALA4418166	A	Effect on renal function in CD1 mouse assessed as effect on blood gas values at 50 mg/kg, ip	Mus musculus	2		organism-based format	Patent Bioactivity Data
18.	ALA4418167	A	Effect on renal function in CD1 mouse assessed as effect on urinary salt excretion at 50 mg/kg, ip measured at 3 hrs	Mus musculus	2		organism-based format	Patent Bioactivity Data
19.	ALA4418168	A	Effect on renal function in C57B/6 mouse assessed as effect on urine pH at 50 mg/kg, ip	Mus musculus	2		organism-based format	Patent Bioactivity Data
20.	ALA4418169	A	Effect on renal function in C57B/6 mouse assessed as effect on blood gas values at 50 mg/kg, ip	Mus musculus	2		organism-based format	Patent Bioactivity Data